Bruker
Trade Bruker 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BRKR
Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the following segments: Bruker Scientific Instruments (BSI) BioSpin, BSI Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID), BSI Nano, and Bruker Energy and Supercon Technologies (BEST).
BRKR Key Statistics
Stock Snapshot
As of today, Bruker(BRKR) shares are valued at $45.67. The company's market cap stands at 6.94B, with a P/E ratio of -288.74 and a dividend yield of 44.3%.
On 2025-12-15, Bruker(BRKR) stock moved within a range of $44.80 to $46.49. With shares now at $45.67, the stock is trading +1.9% above its intraday low and -1.8% below the session's peak.
Trading volume for Bruker(BRKR) stock has reached 1.41M, versus its average volume of 2.33M.
Over the past 52 weeks, Bruker(BRKR) stock has traded between a high of $64.64 and a low of $28.53.
Over the past 52 weeks, Bruker(BRKR) stock has traded between a high of $64.64 and a low of $28.53.
BRKR News
BofA analyst Michael Ryskin raised the firm’s price target on Bruker (BRKR) to $60 from $43 and keeps a Buy rating on the shares. After having spent several day...
Recent Performance and Why Bruker Is Back on Watchlists Bruker (BRKR) has quietly swung from a weak year to a stronger recent stretch, with the stock up about...
Earlier this week, Bruker Corporation reported approximately US$25 million of high-performance magnetic resonance orders from leading French and German research...
Analyst ratings
60%
of 15 ratingsMore BRKR News
Fintel reports that on December 10, 2025, Wolfe Research upgraded their outlook for Bruker Corporation - Preferred Stock (NasdaqGS:BRKRP) from Peer Perform to O...
Wolfe Research upgraded Bruker (BRKR) to Outperform from Peer Perform with a $60 price target The firm cites its 2026 outlook for the upgrade, which assumes low...
Wolfe Research analyst Doug Schenkel upgraded Bruker (BRKR) to Outperform from Peer Perform with a $60 price target Published first on TheFly – the ultimate so...
Bruker (BRKR) announced several European orders for magnetic resonance systems from three research institutions in France and Germany. In the summer, Ecole Norm...
TipRanks Cyber Monday Sale Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRank...